[go: up one dir, main page]

AU2002210527A1 - Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma - Google Patents

Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma

Info

Publication number
AU2002210527A1
AU2002210527A1 AU2002210527A AU1052702A AU2002210527A1 AU 2002210527 A1 AU2002210527 A1 AU 2002210527A1 AU 2002210527 A AU2002210527 A AU 2002210527A AU 1052702 A AU1052702 A AU 1052702A AU 2002210527 A1 AU2002210527 A1 AU 2002210527A1
Authority
AU
Australia
Prior art keywords
combating
sarcoma
carcinoma
bind
sigma receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210527A
Inventor
Christoph Van Amsterdam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2002210527A1 publication Critical patent/AU2002210527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002210527A 2000-10-11 2001-10-11 Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma Abandoned AU2002210527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050236A DE10050236A1 (en) 2000-10-11 2000-10-11 Use of specified compounds as sigma-receptor ligands, useful for treating carcinomas and sarcomas
DE10050236 2000-10-11
PCT/EP2001/011710 WO2002030422A1 (en) 2000-10-11 2001-10-11 Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma

Publications (1)

Publication Number Publication Date
AU2002210527A1 true AU2002210527A1 (en) 2002-04-22

Family

ID=7659331

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210527A Abandoned AU2002210527A1 (en) 2000-10-11 2001-10-11 Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma

Country Status (4)

Country Link
AR (1) AR031725A1 (en)
AU (1) AU2002210527A1 (en)
DE (1) DE10050236A1 (en)
WO (1) WO2002030422A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4737418B2 (en) * 2003-09-25 2011-08-03 塩野義製薬株式会社 Piperidine derivatives having NMDA receptor antagonistic action
TW200621677A (en) * 2004-09-21 2006-07-01 Astellas Pharma Inc Cyclic amine derivative or salt thereof
JP2009515833A (en) * 2005-10-24 2009-04-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 3-piperidin-4-yl-indole ORL-1 receptor modulator
DE102007047737A1 (en) 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidine and piperazine derivatives
AU2010230646B2 (en) * 2009-04-02 2015-11-26 Merck Patent Gmbh Heterocyclic compounds as autotaxin inhibitors
DE102009049211A1 (en) 2009-10-13 2011-04-28 Merck Patent Gmbh sulfoxides
CN105434438B (en) * 2015-12-09 2019-09-17 昆明医科大学 A kind of medicinal usage of Vanoxerine dihydrochloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4017211A1 (en) * 1990-05-29 1991-12-05 Merck Patent Gmbh OXAZOLIDINONE
FR2688504B1 (en) * 1992-03-13 1995-05-05 Synthelabo DERIVATIVES OF 2- (PIPERIDIN-1-YL) ETHANOL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
ES2151930T3 (en) * 1993-07-28 2001-01-16 Santen Pharmaceutical Co Ltd NEW DERIVATIVES OF 1,4- (DIFENILALQUIL) PIPERAZINA.
FR2717806B1 (en) * 1994-03-22 1996-04-26 Adir New aminoalkyl benzothiazolinones, process for their preparation and pharmaceutical compositions containing them.
DE19725664A1 (en) * 1997-06-18 1998-12-24 Merck Patent Gmbh 3-benzylpiperidines

Also Published As

Publication number Publication date
WO2002030422A1 (en) 2002-04-18
DE10050236A1 (en) 2002-04-25
AR031725A1 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001286677A1 (en) Controlled release of substances
IL154272A0 (en) The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0300382A3 (en) 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders and pharmaceutical compositions containing the compounds
AU2001294168A1 (en) Secure distribution of digital content
AU2001292582A1 (en) C-nitroso compounds and use thereof
EP1250116A4 (en) Pharmaceutical and cosmetic carrier or composition for topical application
AU5763101A (en) Anti-inflammatory compounds and uses thereof
AU4436701A (en) Sigma receptor ligands and their medical uses
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2001269474A1 (en) Phenylpyridazine Compounds and Medicines Containing the Same
AU3580001A (en) Modulators of the endocannabinoid uptake and of the vallinoid receptors
AU4478200A (en) Death domain containing receptors
AU2002210527A1 (en) Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma
AU2002236458A1 (en) Texaphyrin coordination compounds and uses thereof
AU2002211621A1 (en) Tricyclic compounds and uses thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
EP1572950A3 (en) Single domain tdf-related compounds and analogs thereof
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
IL156372A0 (en) Carbazole derivatives and pharmaceutical compositions containing the same
AU7104500A (en) Use of rafp to inhibit or prevent apoptosis
AU2001268236A1 (en) Use of aicar and related compounds
AU4432001A (en) Trityl-type compounds and their use